Clinical Trial Update: Switching From Restasis to TRYPTYR [Phase 4]

View source ↗

Summary

Phase 4 study update on switching patients from Restasis to TRYPTYR for dry eye disease, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Restasis (Cyclosporine A)
• TRYPTYR (ACOLTREMON)

Snippet

Sponsor: Southern College of Optometry | Conditions: Dry Eye, Eye Diseases | Phase 4 | Status: NOT_YET_RECRUITING